Legislative tracking for pharma government affairs — every bill, rule and hearing read overnight, scored and briefed with sources
Every bill, rule and hearing that touches our medicines is read overnight and briefed, with sources, to the right policy lead.
See one case, screen by screen ↓A manager’s amendment lands at 21:40. By morning the bill has a new version, a committee vote, a transcript and a new obligation buried in Sec. 4. Somebody has to notice it, read it against the introduced text, work out whether it touches Part D rebates or the 340B channel, and get it to the right VP before the first call of the day — while 50 state legislatures, CMS, FDA and five affordability boards keep moving.
Most of an analyst’s day goes on the reading, not the judgement: checking feeds and dockets, redlining versions by hand, reading hours of hearing transcripts for one mention of a product, and building the same daily brief for five leads. The item that matters most can sit in the queue behind the ones that do not.
Estimated split for one analyst covering a few hundred relevant items a week, by hand and with the solution.
Six specialist agents watch, read, listen, score and brief; a policy analyst confirms every item before it goes out.
Senate Finance reports S. 2187, the PBM delinking bill, 19–8 with a manager’s amendment the evening of October 6. Here is what happens next, screen by screen, in the working solution.
Lena opens the front page to the morning sweep: 1,284 documents read overnight, 318 matched to her seven issues, 7 items at impact 80 or more and 3 waiting for her confirmation. Five briefs are ready for 07:00. The lead story is S. 2187, changed overnight, its impact up from 54 to 86.
“Senate Finance widens PBM delinking to employer plans and adds a quarterly manufacturer rebate report”
Below the lead: H.R. 5530 on biosimilar patents (hearing Oct 15), CMS renegotiation guidance (comments due Nov 14), Illinois SB 1987 on the veto-session calendar, the Section 232 exclusion window (requests due Oct 30). Beside them, what each agent did this morning — 27 new versions redlined, 11 transcripts read, 4 mentions of our products.
The bill opens on its stage track, now at Reported. The agents’ trace shows each step with its time: the new version spotted on the Congress feed, a redline against the introduced text in 2.4 s, the Finance executive session transcript read in 3.1 s, a rescore from 54 to 86, and an alert to Omar Haddad drafted with 6 citations.
Brief Writer: “Alert to Omar Haddad drafted with 6 citations · waiting for your confirmation”
Two sections inserted, two changed, one struck. Sec. 3 extends delinking to group health plans from plan years beginning January 1, 2028. Sec. 4 requires each manufacturer of a covered Part D drug to report every rebate, discount, price concession and fee paid to a PBM, by drug and by plan sponsor, within 90 days of quarter end — with a civil money penalty of up to $100,000 a day. Sec. 5 moves PBM reporting to plan sponsors from semi-annual to quarterly; the rebate pass-through study in Sec. 6 is struck.
Provision records quote the text — never paraphrase it.
The Finance executive session — 2 h 41 min, nine speakers — read and tagged by speaker. The chair at 00:06:48 on employer plans and the quarterly report; the ranking member at 00:11:30 hoping to take the bill to the floor before the end of the year; the clerk at 02:38:40 recording the vote, 19 to 8.
Speakers are quoted exactly, and no vote is inferred that was not recorded.
The score is five factors, each with a reason and a citation: issue match 24 of 25 (PBM reform, priority High), product exposure 21 of 25 (Veltrimab and Corventa; Part D is 41% of Veltrimab’s US net sales), effect on us 19 of 20, likelihood of moving 13 of 20, timing 9 of 10 — it takes effect January 1, 2028, inside the next contracting cycle. If Lena disagrees she moves the slider, and a reason is required.
“Reason (required — it teaches the scorer and goes on the audit trail)”
To Omar Haddad, VP Federal Government Affairs, copy Sam Patel. Three changes that matter: delinking in employer plans from 2028, a quarterly report to HHS of every rebate and fee we pay to PBMs with up to $100,000 a day if late, and quarterly PBM price reports. Why it matters for Veltrimab and Corventa rebate contracts, the clock — the lame-duck floor window opens Nov 16 — and a suggested next step: a position recommendation by Oct 14.
Lena confirms the score as proposed. The alert goes at once — 86 is above the alert threshold of 80 — to Omar, copy Sam Patel, with its 6 citations. Any contact with officials that follows is logged under issue codes PHA and MMM for the quarterly lobbying report.
“Confirmed and sent. Alert went to Omar Haddad, copy Sam Patel · Oct 7 · 06:41, confirmed by Lena Ortiz.”
Omar’s brief now carries S. 2187 marked “Alert already sent”, then the Corventa negotiation clock (the period ends Nov 1), CMS renegotiation guidance and the HELP hearing mention of Veltrimab copay help — ordered act now, this week. Lena can untick an item, write the brief again or preview the email. Nothing leaves until she presses Approve & send.
“Each lead gets only their issues — every sentence cited, and nothing leaves until you approve it.”
The dashboard counts 8,940 documents read in the last 7 days, 2,106 matched and 23 high-impact alerts, each confirmed by an analyst before sending. The median from a change to the lead’s alert fell from 71 minutes on Sep 9 to 38 on Oct 7, and every issue shows how often the analysts confirmed the scores as proposed.
The same amendment, seen by the people who carry it — the analyst who confirms it, and the leads and partners who act on it.
Six specialist agents watch, read, listen, score and brief; a policy analyst confirms every item before it goes out.
Reads Congress, all 50 state legislatures, the Federal Register, agency dockets, affordability boards and committee transcripts — and spots new items and new versions.
Splits each text into sections and pulls the provisions that matter — who must do what, from when, with what penalty — and redlines every new version.
Reads committee and board transcripts the same day, identifies the speakers and pulls every mention of your issues and products.
Scores each item 0–100 against your issue list and products on five factors — issue match, product exposure, effect on you, likelihood of moving and timing — each with its reason and the passage behind it.
Writes the alert or the daily and weekly brief for each lead — only their issues, short, every sentence cited, ordered act now, this week, watching.
When a lead contacts officials about an item, logs the contact with its date, office, item and issue code for the quarterly lobbying report.
Confirms or adjusts every score. The agents propose; a named person decides.
Analysts and leads can ask in plain words — or tell it what to change. Answers carry their citations.
What changed overnight that matters most?
Two tracked items changed status and jumped into high impact: S. 2187, reported 19–8 with a manager’s amendment (54 → 86), and Michigan HB 5814 on 340B, which passed the House 58–50 (66 → 81). The big one is S. 2187: a new quarterly report of every rebate and fee we pay to PBMs, with penalties up to $100,000 a day. Its alert to Omar Haddad waits for your confirmation.
Where are we on the Colorado board and Talmirex?
The Colorado board will decide whether Talmirex is unaffordable. Written comments are due Oct 16, and a finding could lead to an upper payment limit. Oregon’s board is asking for the same power. Dana Okafor has the alert; Sam Patel is copied.
What do the Section 232 tariffs mean for us?
Commerce opened the exclusion window for imported active ingredients used in US manufacture. Requests are due Oct 30. Corventa’s active ingredient is imported, so Priya Raman has it with a suggested next step to file.
Add a rule: alert Dana on any 340B hearing in Tennessee
Done. Any Tennessee committee hearing, interim study or pre-filed bill on 340B now alerts Dana Okafor at once, whatever its score. Tennessee has no active 340B item today; pre-filing for 2027 opens in November. The rule is on in Settings and on the audit trail.
13 screens from the working solution, on its sample data. Pick one to see it large.
What counts as urgent, who hears about it and when is a setting, not a project.
| Setting | Default | Choose from |
|---|---|---|
| Alert the lead at once when impact reaches | 80 | 75 · 80 · 85 |
| Put an item in the daily brief from | 55 | 50 · 55 · 60 |
| Rescore when a tracked item changes | On | New version, new action, hearing or vote |
| Who gets what | A lead per issue | Omar Haddad · Dana Okafor · Sam Patel · Priya Raman · Dr. Maya Chen |
| Priority weight of each issue | High for IRA negotiation, PBM reform, 340B, price caps | High · Medium · Low |
| Daily brief | 07:00 ET | 06:30 · 07:00 · 07:30 ET |
| Weekly leadership brief | Friday 15:00 ET | Friday 15:00 · Monday 08:00 ET |
| Where briefs and alerts arrive | Email and team chat | Email and team chat · Email only |
Every figure is labelled: a target the solution is built to, an estimate, a typical published result, or a proven one.
“demo” = seen in the working solution, on its sample data · “target” = the design goal, measured in the live solution · “estimated” = our estimate before deployment · “typical” = published public-affairs benchmarks (130,000+ US state bills in 2025). People, products and bill details named on this page are characters and sample data in the working solution.
Software that follows bills, rules, guidance, comment dockets, board actions and hearings that affect your medicines, and tells the right person when something changes. Policy and Legislation Radar adds agents that read every new version, score it against your issue list and products, and draft a cited alert or brief for each policy lead.
The Impact Scorer gives each item 0–100 on five factors: issue match, product exposure, effect on the company, likelihood of moving and timing. Each factor has a short reason and cites the passage or transcript line behind it, and a rescore shows the old and new values.
No. Scores are proposals until an analyst confirms, adjusts or sets the item to watch only, and every alert and brief waits for analyst approval. An adjusted score needs a reason, which goes on the audit trail.
Congress, all 50 state legislatures and DC, the Federal Register, CMS, FDA, HRSA and FTC comment dockets, state affordability boards and committee hearing transcripts — public sources only. A commercial bill-tracking feed can be added alongside if you use one.
Yes. State bills, amendments, votes and calendars are read every sweep, and board agendas from Colorado, Oregon, Maryland, Minnesota and Washington are followed. Each item shows its stage and next clock, and state items go to the state affairs lead unless you route them elsewhere.
Yes. When a lead records a contact with an official that follows from an alert, the Disclosure Linker logs it with the date, office, item and issue code for the quarterly report, and flags entries with no issue code before the quarter closes. Government affairs operations approves the log.
Yes. You add issues in plain words, set each one’s priority weight and lead, and choose the alert threshold, the daily-brief threshold, brief times and delivery. Change a weight and every score updates.
The Agentic Solution Engine builds and deploys it from your requirements — your issue list, products and leads — and it goes live once every quality gate has passed. We will walk you through it on your own issues and this week’s items first.
Every sustainability questionnaire is answered from one evidence library, each answer cited, checked and approved by its owner.
1-min filmEarnings Q&AEvery likely analyst question forecast and answered from approved disclosures, each line cited.
1-min filmPitch TriageEvery partnering pitch read, scored and answered within days, with any earlier decision on the same asset brought back.
1-min filmWe’ll run Policy and Legislation Radar on your issues, your products and this week’s bills and rules.